Technical Analysis for GUD - Knight Therapeutics Inc.

Grade Last Price % Change Price Change
grade C 7.57 2.30% 0.170
GUD closed up 2.3 percent on Friday, October 11, 2019, on 1.44 times normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Flat Flat Up
See historical GUD trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Cup with Handle Other 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Resistance Bearish 2.30%
Shooting Star Candlestick Bearish 2.30%

Older signals for GUD ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.
Health Pharmaceutical Pharmaceutical Industry Pharmaceutical Products Pharmaceutical Industry In China Pharmaceutical Sciences Consumer Health Products
Is GUD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.69
52 Week Low 7.1
Average Volume 221,737
200-Day Moving Average 7.5792
50-Day Moving Average 7.5774
20-Day Moving Average 7.449
10-Day Moving Average 7.418
Average True Range 0.1049
ADX 15.08
+DI 24.1095
-DI 16.4748
Chandelier Exit (Long, 3 ATRs ) 7.5753
Chandelier Exit (Short, 3 ATRs ) 7.6347
Upper Bollinger Band 7.5761
Lower Bollinger Band 7.3219
Percent B (%b) 0.98
BandWidth 3.412539
MACD Line -0.0458
MACD Signal Line -0.056
MACD Histogram 0.0102
Fundamentals Value
Market Cap 1.08 Billion
Num Shares 143 Million
EPS 0.14
Price-to-Earnings (P/E) Ratio 54.07
Price-to-Sales 154.65
Price-to-Book 1.26
PEG Ratio 2876.67
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.870
Resistance 3 (R3) 7.840 7.710 7.820
Resistance 2 (R2) 7.710 7.634 7.725 7.803
Resistance 1 (R1) 7.640 7.586 7.675 7.670 7.787
Pivot Point 7.510 7.510 7.528 7.525 7.510
Support 1 (S1) 7.440 7.434 7.475 7.470 7.353
Support 2 (S2) 7.310 7.386 7.325 7.337
Support 3 (S3) 7.240 7.310 7.320
Support 4 (S4) 7.270